Posted by Michael Wonder on 30 Mar 2026
Leading cancer drug subsidised for thousands of patients
29 March 2026 - Health Minister Mark Butler has expanded the PBS listing of a leading cancer drug, giving more than 10,000 Australians access to affordable treatment.
From 1 April 2026, the PBS listing of pembrolizumab – known as Keytruda – will be expanded to include treatment of three additional cancers: high risk, locally advanced cervical cancer, renal cell carcinoma, and locally advanced head and neck squamous cell carcinoma.
